However, the curves showed that TOP3B expression above or below the median in all NSCLC patients did not separate cases into significantly different prognostic cohorts (HR 0.97 [0.85–1.11], p = 0.67) (Fig 7A). Here, TOP3B is linked to non-small cell lung carcinoma.